BioCentury
ARTICLE | Finance

The return of big

Highlights of public-private partnerships from 3Q17

November 9, 2017 9:20 PM UTC

After a slow second quarter, pharmas have stepped up their activity in public-private partnerships, announcing 13 in 3Q17, compared with only five in the quarter before. The deals bring the third quarter total to 56, almost double the number signed in the same quarter last year, and putting the numbers on track to match or exceed the year total of 2016.

The numbers suggest the drop in new PPPs last year compared with 2015 may have been a dip rather than a trend, with this year’s numbers leveling off, if not growing, and remaining constant through all three quarters. But in all, the activity is far off the heyday of 2012 (see “PPPs and Consortia Activity by Quarter”)...